|1.||McDonald, Jay M: 11 articles (09/2015 - 03/2003)|
|2.||Shirasaki, Yasufumi: 10 articles (01/2011 - 03/2003)|
|3.||Tang, Wei-Jen: 8 articles (07/2015 - 01/2002)|
|4.||Chen, Yabing: 7 articles (09/2015 - 02/2008)|
|5.||Anderson, Mark E: 7 articles (12/2012 - 02/2002)|
|6.||Bers, Donald M: 6 articles (06/2015 - 12/2005)|
|7.||Delivoria-Papadopoulos, Maria: 6 articles (08/2011 - 04/2002)|
|8.||Zhuo, Min: 6 articles (08/2006 - 06/2002)|
|9.||Maier, Lars S: 5 articles (06/2015 - 03/2007)|
|10.||George, Alfred L: 5 articles (09/2014 - 03/2013)|
06/01/2005 - "Treatment with calmodulin antagonist EBB is effective in suppressing tumor invasion. "
01/01/2013 - "The purpose of this study was to determine if the epithelial-specific human calmodulin-like protein (CALML3) could be used as marker for the various phases of oral tumor progression. "
12/01/1996 - "The study also suggests the possibility that a calmodulin antisense approach may be used to inhibit the proliferation of neuronal tumors."
07/29/1983 - "Previous studies using animal tumor models have suggested a positive correlation between tumor calmodulin content and rate of tumor growth. "
09/01/2015 - "Calmodulin can contribute to initiation/progression of ductal cancers via both PI3Kα/Akt and Raf/MEK/ERK pathways. "
04/09/1992 - "Additionally, interfering with calmodulin's role in sympathetic nerve terminal function may help to limit the ischemia-induced catecholamine release that contributes to arrhythmogenesis. "
01/01/2002 - "In the present study, we investigated the activity and expression of calmodulin-dependent cyclic nucleotide phosphodiesterase (CaMPDE) and the effects of calpains in rat heart after ischemia and reperfusion. "
07/01/2000 - "This study aimed to evaluate the effect of calmodulin antagonists on the threshold of the compound action potential (CAP) and the functional recovery of the cochlea after transient ischemia. "
05/01/1992 - "We also undertook a histochemical study for calmodulin, which we found useful in the diagnosis of early ischemia. "
05/05/2013 - "Calmodulin expression was lowest in the adaptive ischemia/reperfusion group. "
|3.||Psoriasis (Pustulosis Palmaris et Plantaris)
12/01/1985 - "Calmodulin levels in the involved epidermis of patients with psoriasis were significantly greater than in epidermis of control subjects, with both methods of calmodulin measurement. "
08/01/1986 - "Epidermal calmodulin (CaM) has been reported to be elevated in psoriasis and to decrease following clearance of psoriasis with treatment. "
01/01/1996 - "The aim of the study was to make a selection of the calmodulin antagonists, which could be useful in topical treatment of psoriasis. "
01/01/1991 - "Various studies have suggested that calmodulin (CaM) is involved in the pathophysiology of psoriasis. "
03/01/1984 - "The aim of this study was to determine whether levels of biologically active calmodulin are elevated in both lesional and uninvolved epidermis in psoriasis. "
06/01/2008 - "Effect of CV159-Ca(2+)/calmodulin blockade on redox status hepatic ischemia-reperfusion injury in mice evaluated by a newly developed in vivo EPR imaging technique."
07/01/2000 - "These results suggest that the action antagonizing calmodulin has no effect on the CAP threshold, while the role that calmodulin plays in cochlear ischemia-reperfusion injury still remains unclear."
03/01/1991 - "Protective effect of calmodulin inhibitors on reperfusion injury."
01/01/1989 - "[Protection of myocytes against reperfusion injury by calmodulin inhibition]."
01/01/1994 - "Further assessment of the protective effect of calmodulin inhibitors against reperfusion injury after acute coronary occlusion in the dog."
01/01/1989 - "4. The present experiments suggest that calmodulin antagonists may be effective drugs in treatment of burns, having both therapeutic and prophylactic action."
01/01/1989 - "Therapeutic and prophylactic treatment of skin burns with several calmodulin antagonists."
07/01/1994 - "These in vitro studies suggest that burn blister fluid may promote wound healing, and locally released calmodulin contributes to this effect. "
01/01/1991 - "Here we show that CGS 9343B, like other calmodulin antagonists reported previously, is most effective in treatment of burns. "
10/10/1996 - "These results suggest that some calmodulin antagonists and anesthetics in water-soluble bases might be a choice for the treatment of 2-chloroethylethyl sulfide-induced skin burns."
|4.||Protein Kinases (Protein Kinase)
|8.||3- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrate
|9.||Calcium-Calmodulin-Dependent Protein Kinase Type 2
|10.||W 7 (W7)
|3.||Combination Drug Therapy (Combination Chemotherapy)
|4.||Drug Therapy (Chemotherapy)